EW
Edwards Lifesciences Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$81.81
-2.80 ▼ -3.31%
🌙 3월 13일 7:45 PM ET (한국 3/14 08:45)
$83.44
+1.63 ▲ +1.99%
| Index | S&P 500 | P/E | 45.29 | EPS (ttm) | 1.81 | Insider Own | 1.4% | Shs Outstand | 0.58B | Perf Week | 0.21% |
| Market Cap | 47.52B | Forward P/E | 24.66 | EPS next Y | 11.8% | Insider Trans | -1.93% | Shs Float | 0.57B | Perf Month | 3.13% |
| Enterprise Value | 43.99B | PEG | 1.84 | EPS next Q | 0.73 | Inst Own | 88.31% | Short Float | 2.16% | Perf Quarter | -2.51% |
| Income | 1.06B | P/S | 7.83 | EPS this Y | 15.9% | Inst Trans | 0.6% | Short Ratio | 2.89 | Perf Half Y | 4.87% |
| Sales | 6.07B | P/B | 4.6 | EPS next 5Y | 13.37% | ROA | 7.93% | Short Interest | 12.38M | Perf YTD | -4.04% |
| Book/sh | 17.8 | P/C | 11.24 | EPS past 3/5Y | -9.46% 6.79% | ROE | 10.43% | 52W High | -6.92% ($87.89) | Perf Year | 20.4% |
| Cash/sh | 7.28 | P/FCF | 35.59 | Sales past 3/5Y | 4.08% 6.7% | ROIC | 9.62% | 52W Low | 24.07% ($65.94) | Perf 3Y | 6.77% |
| Dividend Est. | - | EV/EBITDA | 24.62 | EPS Y/Y TTM | 23.65% | Gross Margin | 77.91% | Volatility(W/M) | 3.86% 3.06% | Perf 5Y | -0.32% |
| Dividend TTM | - | EV/Sales | 7.25 | Sales Y/Y TTM | 6% | Oper. Margin | 26.87% | ATR (14) | 2.59 | Perf 10Y | 180.08% |
| Dividend Ex-Date | - | Quick Ratio | 3.09 | EPS Q/Q | -83.09% | Profit Margin | 17.47% | RSI (14) | 46.44 | Recom | 1.79 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.72 | Sales Q/Q | 13.26% | SMA20 | -1.28% ($82.87) | Beta | 0.93 | Target Price | $96.97 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2000000 | SMA50 | -0.99% ($82.63) | Rel Volume | 1.31 | Prev Close | $84.61 |
| Employees | 16000 | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | -6.13% 1.47% | SMA200 | 1.9% ($80.28) | Avg Volume(3M) | 4.28M | Price | $81.81 |
| IPO | 2000/3/27 | Option/Short | Yes/Yes | Trades | 43715 | Volume | 5,617,579 | Change | -3.31% |
뉴스 로딩 중...